Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention
Part of paid clinical trials in Washington D.C., District of Columbia.
- Sponsor
- University of Maryland, College Park
- Study ID
- NCT05973838
- Status
- Recruiting
Conditions
- Opioid Medication Assisted Treatment
- Polysubstance Addiction
- Retention in Care
- Substance-Related Disorders
- Treatment Adherence
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Peer-Delivered Behavioral Activation ("Peer Activate") — BEHAVIORALThe PRS-delivered Peer Activate intervention will consist of approximately six weekly "core" sessions (approximately 30 minutes-1 hour), and then 6 optional "booster" sessions to reinforce skill practice. In Peer Activate sessions, participants will learn behavioral activation and problem-solving skills to reduce barriers to medication nonadherence and incorporate value-driven, substance-free, rewarding activities into their daily life to reduce polysubstance use and improve retention.
Study Details
The purpose of this study is to evaluate the feasibility and effectiveness of a peer-led, brief, behavioral intervention to improve adherence to medication for opioid use disorder (MOUD) and reduce polysubstance use among patients with OUD and polysubstance use in underserved areas. The intervention is based on behavioral activation (BA) and is specifically designed to be implemented by a trained peer recovery specialist. In this hybrid, Type-1 effectiveness-implementation randomized controlled trial (RCT), the investigators will evaluate the effectiveness and implementation of Peer Activate vs. treatment as usual (TAU) over twelve months.
Key Dates
- Start date
- Jun 15, 2023
- Status verified
- Apr 2026
- Primary completion
- Jul 1, 2027
- Completion
- Sep 1, 2027
Study Design
- Enrollment
- 160 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Peer-Delivered Behavioral Activation ("Peer Activate")Participants in the Peer Activate intervention will receive a PRS-delivered behavioral activation intervention to address barriers to retention in methadone treatment and increase substance-free, positive reinforcement to support retention and reduce polysubstance use.
- No Intervention: Treatment As UsualParticipants in the TAU group will receive enhanced treatment as usual, defined as MTU services as usual enhanced with additional community referrals and follow-ups on those referrals, in addition to regular meetings with an addiction medicine physician and PRS on the MTU. Standard PRS contact typically includes connection to local resources and general peer support as needed.
Primary Outcome Measure
Six-Month Polysubstance Use Urinalysis [ Time Frame: Measured from baseline to 6-month follow-up ]
Central Contacts
- Morgan S Anvari, BA3014055095
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| HIPS Clinic | Washington D.C. | District of Columbia | 20002 | |
| University of Maryland Baltimore (UMD Drug Treatment Center) | Baltimore | Maryland | 21223 | Sarah M Kattakuzhy, MD (PRINCIPAL_INVESTIGATOR) Eric Weintraub, MD (SUB_INVESTIGATOR) Annabelle M Belcher, PhD (SUB_INVESTIGATOR) |
| University of Maryland, College Park | College Park | Maryland | 20742 | Jessica F Magidson, PhD (PRINCIPAL_INVESTIGATOR) |
| Caroline County Behavioral Health | Denton | Maryland | 21629 |
Find similar trials in Washington D.C., DC
Related Studies
- GLP-1R Agonist Treatment for Opioid Use DisorderPHASE2 · Recruiting · Milton S. Hershey Medical Center · Baltimore, Maryland
- SMART-r: Substance Monitoring and Active Relapse Tracking RepositoryRecruiting · National Institute on Drug Abuse (NIDA) · Baltimore, Maryland
- Alliances to Disseminate Addiction Prevention and Treatment (ADAPT)Enrolling By Invitation · Indiana University · Indianapolis, Indiana
- CRP and S&A for Inpatient VeteransRecruiting · VA Office of Research and Development · Charleston, South Carolina